The hazards of chasing subgroups in neutral stroke trials

Area of Science:

• Clinical Trials
• Neurology
• Stroke Research

Background:

• Many randomized controlled trials (RCTs) in acute stroke and prevention studies yield neutral results, failing to reach statistical significance.
• However, some trials identify apparent benefits within specific subgroups, prompting follow-up investigations.
• Evidence suggests these follow-on trials are frequently neutral.

Purpose of the Study:

• To discuss the issue of pursuing subgroup findings in neutral stroke trials.
• To illustrate the challenges encountered in such follow-up studies using exemplar trials.
• To provide guidance for future research to avoid common pitfalls.

Main Methods:

• Analysis of five pairs of exemplar acute stroke trials.
• Discussion of common problems in trial design and reporting related to subgroup analysis.
• Review of criteria for valid subgroup investigation.

Main Results:

• Identified issues include: undefined or changing subgroup definitions, lack of statistical significance in interaction tests and primary outcomes, insufficient reporting of positive subgroup data, excessive number of subgroups, inadequate trial size, and failure to report follow-on trial findings.
• These issues highlight the difficulties in reliably pursuing subgroup benefits.

Conclusions:

• For subgroup analyses to be valid, the subgroup must be biologically plausible, defined a priori, and supported by a significant interaction test.
• The component of interest must be statistically significant, with a limited number of subgroups investigated.
• Follow-on trials require clear explanations for positive components, demonstration of benefit in other outcomes, and adherence to rigorous methodological standards to avoid likely neutral outcomes.